AI English summary of an SEC filing — figures as filed
IDEXX Laboratories said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation at the annual meeting held on May 12, 2026 to declassify the Board over 3 years and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders.
Key points
AI summaryIDEXX Laboratories said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation at the annual meeting held on May 12, 2026 to declassify the Board over 3 years and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders.
The company said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation to provide shareholders owning at least 25% of the shares of the Corporation's capital stock continuously for at least 1 year the right to have the Corporation call a special meeting of shareholders, subject to additional terms, conditions, limitations and procedures as set forth in the Corporation's By-Laws.
IDEXX Laboratories said a Certificate of Amendment reflecting the approved amendments was filed with the Secretary of State of the State of Delaware and became effective on May 13, 2026, and the Corporation's By-Laws were amended and restated effective upon the filing of the Certificate of Amendment on the same date.
The company disclosed that on the shareholder proposal to give shareholders the ability to call for a special shareholder meeting, voting results were 28,179,566 for, 40,019,951 against and 227,294 abstentions, and on the proposal to amend the Certificate of Incorporation to provide shareholders owning 25% of the shares the right to call a special meeting, voting results were 63,934,239 for.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Board declassification amendment approved
IDEXX Laboratories said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation at the annual meeting held on May 12, 2026 to declassify the Board over 3 years and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders.
Source · Based on the filing body and exhibits
Special meeting call right amendment approved
The company said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation to provide shareholders owning at least 25% of the shares of the Corporation's capital stock continuously for at least 1 year the right to have the Corporation call a special meeting of shareholders, subject to additional terms, conditions, limitations and procedures as set forth in the Corporation's By-Laws.
Source · Based on the filing body and exhibits
Certificate amendment effective; By-Laws amended
IDEXX Laboratories said a Certificate of Amendment reflecting the approved amendments was filed with the Secretary of State of the State of Delaware and became effective on May 13, 2026, and the Corporation's By-Laws were amended and restated effective upon the filing of the Certificate of Amendment on the same date.
Source · Based on the filing body and exhibits
Shareholder proposal and special meeting call right voting results
The company disclosed that on the shareholder proposal to give shareholders the ability to call for a special shareholder meeting, voting results were 28,179,566 for, 40,019,951 against and 227,294 abstentions, and on the proposal to amend the Certificate of Incorporation to provide shareholders owning 25% of the shares the right to call a special meeting, voting results were 63,934,239 for.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…